5-bromo-2-hydroxybenzamide,
5-Bromosalicylamide,
6329-74-4,
Bromosalicylamide,
Salicylamide, bromo-,
Salicylamide, 5-bromo-,
5-bromo-2-hydroxy-benzamide,
Benzamide, 5-bromo-2-hydroxy-,
UNII-XQU5NZU8HR,
XQU5NZU8HR,
EINECS 228-704-5,
NSC 14278,
BRN 3530373,
Benzamide,5-bromo-2-hydroxy-,
5-Bromsalicylamid,
NSC14278,
5-bromo salicylamide,
AC1Q4ZAF,
WLN: ZVR BQ XE,
ACMC-1B7TF,
5-Bromosalicylamide, 97%,
AC1L2IV2,
AC1Q25MM,
1-10-00-00048 (Beilstein Handbook Reference),
SCHEMBL1175614,
CTK5B8535,
KS-00000LHK,
Salicylamide, 5-bromo- (8CI),
DTXSID40212685,
MRMOPHYFXXZTFN-UHFFFAOYSA-N,
ZINC400551,
ACT02751,
ANW-47551,
MFCD00157694,
NSC-14278,
AKOS015916746,
CS-W022309,
MCULE-8792585476,
RP26955,
VZ30157,
Benzamide, 5-bromo-2-hydroxy- (9CI),
AJ-21791,
AK-25187,
AN-25413,
BR-25187,
DS-10661,
SY046600,
ZB012837,
DB-054453,
LS-144140,
ST2418640,
TC-136296,
4CH-014174,
FT-0636096,
MFCD00157694 (97%),
J-517210,
I14-51048,
Z68590257,
InChI=1/C7H6BrNO2/c8-4-1-2-6(10)5(3-4)7(9)11/h1-3,10H,(H2,9,11,
C7H6BrNO2,
C7-H6-Br-N-O2,
CID72876,
AR-1G7399,
64038-61-5,